Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.

L. Singh, Siân Lewis, Mark J. Field et al. · Proceedings of the National Academy of Sciences · 1991 · 214 citations

Medicine, Neuroscience, Pharmacology +13

The Panicogenic Effects of Cholecystokinin-Tetrapeptide Are Antagonized by L-365,260, a Central Cholecystokinin Receptor Antagonist, in Patients With Panic Disorder

Jacques Bradwejn · Archives of General Psychiatry · 1994 · 180 citations

Medicine, Pharmacology, Pharmacotherapy +13

A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder

Mark S. Kramer, Neal R. Cutler, James C. Ballenger et al. · Biological Psychiatry · 1995 · 117 citations

Medicine, Pharmacology, Psychiatry +14

Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients

Harold J.G.M. van Megen, H.G.M. Westenberg, Johan A. den Boer et al. · Psychopharmacology · 1994 · 110 citations

Medicine, Pharmacology, Psychiatry +12

Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients

Jacques Bradwejn, Diana Koszycki · American Journal of Psychiatry · 1994 · 91 citations

Medicine, Pharmacology, Psychiatry +16